|
US2021022800A1
|
|
Inducing internal apoptosis in malignant tumors by positive electrostatic charges
|
|
US2021007638A1
|
|
Real-time and label free analyzer for in-vitro and in-vivo detecting the suspicious regions to cancer
|
|
WO2021053631A2
|
|
Electrostatic drug delivery
|
|
US2021063341A1
|
|
Electromechanical approach for cancer detection
|
|
US2020393439A1
|
|
Method and system for metastasis diagnosis and prognosis
|
|
US2020340945A1
|
|
Electrochemical approach for COVID-19 detection
|
|
US10786188B1
|
|
Real-time and label free analyzer for in-vitro and in-vivo detecting the suspicious regions to cancer
|
|
US2020209181A1
|
|
Electrochemical method and device for detecting the effect of anticancer drugs
|
|
WO2020079533A1
|
|
Electrochemical lipidomics for cancer diagnosis
|
|
WO2019243902A1
|
|
Electrochemical biosensor and method to monitor biological cells behavior in acidic conditions
|
|
WO2019012400A1
|
|
Metastatic cancer diagnosis via detecting ph-dependent activation of autophagy in invasive cancer cells
|
|
WO2019008508A2
|
|
Inducing internal apoptosis in malignant tumors by positive electrostatic charges
|
|
EP3638112A1
|
|
Real-time and label free analyzer for in-vitro and in-vivo detecting the suspicious regions to cancer
|
|
WO2018198008A1
|
|
In-situ microbubbles generation for ultrasonic biomedical applications
|
|
EP3634573A1
|
|
Ultrasound-assisted electrochemical distinction of normal and cancerous cells
|
|
US2018149652A1
|
|
Electrical cell-substrate impedance sensor (ecis)
|
|
US2017350876A1
|
|
Biosensor for single cell analysis
|
|
US2018100849A1
|
|
Method and system for metastasis diagnosis and prognosis
|
|
US2017269087A1
|
|
Method and system for metastasis diagnosis and prognosis
|
|
US2017244110A1
|
|
Integrated methods and systems for electrical monitoring of cancer cells stimulated by electromagnetic waves
|
